KRAS and non-small cell lung carcinoma: During the previous decades, numerous genetic variations have been described in NSCLC, including epidermal growth factor receptor (EGFR), KRAS and anaplastic lymphoma kinase (ALK), as the most commonly altered oncogenes acting as tumor driver genes.6